
Infliximab treatment of glycogenosis Ib with Crohn's-like enterocolitis: A case report
Author(s) -
Y Z Gong,
Xuemei Zhong,
Jizhen Zou
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i19.5280
Subject(s) - medicine , infliximab , enterocolitis , crohn's disease , gastroenterology , disease
Glycogen storage disease type Ib (GSD-Ib) is a glycogen metabolism disorder that leads to the manifestations of inflammatory bowel disease (IBD), especially Crohn's disease (CD)-like colitis. Although biological agents are effective for treating CD, their application in the treatment of GSD-Ib with CD-like colitis has been rarely reported.